Cell & Gene Therapy

Explore news and insight around cell and gene therapy, including new technology and information in this evolving biotech field. Read on to understand how the industry is addressing gene therapy and cell therapy research and development.

Brought to you by:
An illustration of a white strand of DNA which lies horizontally across an image
Biotech

Ultragenyx tweaks gene therapy dosing to dial up efficacy

A minority of patients have come off standard-of-care drugs, leading the biotech to enroll a new cohort on a tweaked regimen to dial up the efficacy.
Nick Paul Taylor Oct 4, 2024 8:46am
gene edits scientists gene editing CRISPR

Editas cashes in on Vertex Cas9 licensing agreement for $57M

Oct 4, 2024 5:06am
Hong Kong

Zephyrm seeks Hong Kong IPO to fund phase 3 cell therapy trials

Oct 2, 2024 8:19am
Board room C-suite meeting contract

IGM pivots from cancer to autoimmune, shaking up C-suite

Oct 1, 2024 7:05am
gene edits scientists gene editing CRISPR

BMS pays Prime $110M to form T-cell therapy pact

Sep 30, 2024 7:18am
cancer target detection radiopharma radio

Flagship hopes biotechs flock to Mirai to boost genetic meds

Sep 26, 2024 6:00am
More News

Aptadir hopes new RNA inhibitors can reverse tricky cancers

Sep 24, 2024 9:50am

Potential new Alzheimer's drugs target tangles of tau

Sep 19, 2024 2:42pm

New cell therapy biotech emerges from the lab of George Church

Sep 19, 2024 6:30am

Novo Nordisk signs $530M biobucks deal to sing in Korro's opera

Sep 16, 2024 9:40am